Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres

EMBO Journal

Volumn 35, Issue 2, 2016, Pages 193-207

  Tutton, Stephen ^a   Azzam, Greggory A ^a   Stong, Nicholas ^a   Vladimirova, Olga ^a   Wiedmer, Andreas ^a   Monteith, Jessica A ^b   Beishline, Kate ^a   Wang, Zhuo ^a   Deng, Zhong ^a   Riethman, Harold ^a   McMahon, Steven B ^b   Murphy, Maureen ^a   Lieberman, Paul M ^a  

^a WISTAR INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

chromatin; DNA damage; telomere; TERRA; TP53; tumor suppressor

Indexed keywords

DNA; GAMMA HISTONE H2AX; HISTONE H2AX; HISTONE H3; PROTEIN P53; RNA; UNCLASSIFIED DRUG; CARRIER PROTEIN; PROTEIN BINDING;

ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; DNA DAMAGE; DNA DEGRADATION; DNA REPAIR; DNA SEQUENCE; HISTONE ACETYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; TELOMERE; GENETICS; HCT 116 CELL LINE; METABOLISM;

CARRIER PROTEINS; DNA DAMAGE; HCT116 CELLS; HUMANS; PROTEIN BINDING; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84955389853     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.15252/embj.201490880     Document Type: Article

References (58)

1. Al Rashid ST, Dellaire G, Cuddihy A, Jalali F, Vaid M, Coackley C, Folkard M, Xu Y, Chen BP, Chen DJ, Lilge L, Prise KM, Bazett Jones DP, Bristow RG, (2005) Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. Cancer Res 65: 10810-10821
2. Al Rashid ST, Harding SM, Law C, Coackley C, Bristow RG, (2011) Protein-protein interactions occur between p53 phosphoforms and ATM and 53BP1 at sites of exogenous DNA damage. Radiat Res 175: 588-598
3. Allen MA, Andrysik Z, Dengler VL, Mellert HS, Guarnieri A, Freeman JA, Sullivan KD, Galbraith MD, Luo X, Kraus WL, Dowell RD, Espinosa JM, (2014) Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. eLife 3: e02200
4. Ambrosini A, Paul S, Hu S, Riethman H, (2007) Human subtelomeric duplicon structure and organization. Genome Biol 8: R151
5. Arora R, Brun CM, Azzalin CM, (2011) TERRA: Long Noncoding RNA at Eukaryotic Telomeres. Prog Mol Subcell Biol 51: 65-94
6. Azzalin CM, Lingner J, (2014) Telomere functions grounding on TERRA firma. Trends Cell Biol 25: 29-36
7. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J, (2007) Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318: 798-801
8. Bah A, Azzalin CM, (2012) The telomeric transcriptome: from fission yeast to mammals. Int J Biochem Cell Biol 44: 1055-1059
9. Baur JA, Zou Y, Shay JW, Wright WE, (2001) Telomere position effect in human cells. Science 292: 2075-2077
10. Bieging KT, Attardi LD, (2012) Deconstructing p53 transcriptional networks in tumor suppression. Trends Cell Biol 22: 97-106
11. Bieging KT, Mello SS, Attardi LD, (2014) Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14: 359-370
12. Blackburn EH, (2005) Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 579: 859-862
13. Caslini C, Connelly JA, Serna A, Broccoli D, Hess JL, (2009) MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Mol Cell Biol 29: 4519-4526
14. Cech TR, (2004) Beginning to understand the end of the chromosome. Cell 116: 273-279
15. Chang GS, Chen XA, Park B, Rhee HS, Li P, Han KH, Mishra T, Chan-Salis KY, Li Y, Hardison RC, Wang Y, Pugh BF, (2014) A comprehensive and high-resolution genome-wide response of p53 to stress. Cell Rep 8: 514-527
16. Cui F, Sirotin MV, Zhurkin VB, (2011) Impact of Alu repeats on the evolution of human p53 binding sites. Biology Direct 6: 2
17. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B, (1992) Definition of a consensus binding site for p53. Nat Genet 1: 45-49
18. Deng Z, Norseen J, Wiedmer A, Riethman H, Lieberman PM, (2009) TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell 35: 403-413
19. Deng Z, Wang Z, Stong N, Plasschaert R, Moczan A, Chen HS, Hu S, Wikramasinghe P, Davuluri RV, Bartolomei MS, Riethman H, Lieberman PM, (2012a) A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. EMBO J 31: 4165-4178
20. Deng Z, Wang Z, Xiang C, Molczan A, Baubet V, Conejo-Garcia J, Xu X, Lieberman PM, Dahmane N, (2012b) Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma. J Cell Sci 125: 4383-4394
21. Feuerhahn S, Iglesias N, Panza A, Porro A, Lingner J, (2010) TERRA biogenesis, turnover and implications for function. FEBS Lett 584: 3812-3818
22. Higgins DG, Thompson JD, Gibson TJ, (1996) Using CLUSTAL for multiple sequence alignments. Methods Enzymol 266: 383-402
23. Kenzelmann Broz D, Spano Mello S, Bieging KT, Jiang D, Dusek RL, Brady CA, Sidow A, Attardi LD, (2013) Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev 27: 1016-1031
24. Kung CP, Khaku S, Jennis M, Zhou Y, Murphy ME, (2015) Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes. Mol Cancer Res 13: 250-262
25. Lane DP, (1992) Cancer. p53, guardian of the genome. Nature 358: 15-16
26. de Lange T, (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100-2110
27. Lee TI, Johnstone SE, Young RA, (2006) Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat Protoc 1: 729-748
28. Leveille N, Melo CA, Rooijers K, Diaz-Lagares A, Melo SA, Korkmaz G, Lopes R, Akbari Moqadam F, Maia AR, Wijchers PJ, Geeven G, den Boer ML, Kalluri R, de Laat W, Esteller M, Agami R, (2015) Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat Commun 6: 6520
29. Melo CA, Drost J, Wijchers PJ, van de Werken H, de Wit E, Oude Vrielink JA, Elkon R, Melo SA, Leveille N, Kalluri R, de Laat W, Agami R, (2013) eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell 49: 524-535
30. Moon SH, Lin L, Zhang X, Nguyen TA, Darlington Y, Waldman AS, Lu X, Donehower LA, (2010) Wild-type p53-induced phosphatase 1 dephosphorylates histone variant gamma-H2AX and suppresses DNA double strand break repair. J Biol Chem 285: 12935-12947
31. Nergadze SG, Farnung BO, Wischnewski H, Khoriauli L, Vitelli V, Chawla R, Giulotto E, Azzalin CM, (2009) CpG-island promoters drive transcription of human telomeres. RNA 15: 2186-2194
32. Olivier M, Hollstein M, Hainaut P, (2010) TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2: a001008
33. Palm W, de Lange T, (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42: 301-334
34. Porro A, Feuerhahn S, Delafontaine J, Riethman H, Rougemont J, Lingner J, (2014) Functional characterization of the TERRA transcriptome at damaged telomeres. Nat Commun 5: 5379
35. Redon S, Reichenbach P, Lingner J, (2010) The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res 38: 5797-5806
36. Riethman H, (2008) Human subtelomeric copy number variations. Cytogenet Genome Res 123: 244-252
37. Riethman H, Ambrosini A, Paul S, (2005) Human subtelomere structure and variation. Chromosome Res 13: 505-515
38. Robin JD, Ludlow AT, Batten K, Magdinier F, Stadler G, Wagner KR, Shay JW, Wright WE, (2014) Telomere position effect: regulation of gene expression with progressive telomere shortening over long distances. Genes Dev 28: 2464-2476
39. Rumble SM, Lacroute P, Dalca AV, Fiume M, Sidow A, Brudno M, (2009) SHRiMP: accurate mapping of short color-space reads. PLoS Comput Biol 5: e1000386
40. Sacconi S, Salviati L, Desnuelle C, (2014) Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta 1852: 607-614
41. Sanjana NE, Shalem O, Zhang F, (2014) Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11: 783-784
42. Schlereth K, Heyl C, Krampitz AM, Mernberger M, Finkernagel F, Scharfe M, Jarek M, Leich E, Rosenwald A, Stiewe T, (2013) Characterization of the p53 cistrome-DNA binding cooperativity dissects p53's tumor suppressor functions. PLoS Genet 9: e1003726
43. Schoeftner S, Blasco MA, (2008) Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol 10: 228-236
44. Serrano MA, Li Z, Dangeti M, Musich PR, Patrick S, Roginskaya M, Cartwright B, Zou Y, (2013) DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair. Oncogene 32: 2452-2462
45. Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, Bashashati A, Prentice LM, Khattra J, Burleigh A, Yap D, Bernard V, McPherson A, Shumansky K, Crisan A, Giuliany R, et al, (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486: 395-399
46. Shiekhattar R, (2013) Opening the Chromatin by eRNAs. Mol Cell 51: 557-558
47. Sigal A, Rotter V, (2000) Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res 60: 6788-6793
48. de Silanes IL, Grana O, De Bonis ML, Dominguez O, Pisano DG, Blasco MA, (2014) Identification of TERRA locus unveils a telomere protection role through association to nearly all chromosomes. Nat Commun 5: 4723
49. Stadler G, Rahimov F, King OD, Chen JC, Robin JD, Wagner KR, Shay JW, Emerson CP Jr, Wright WE, (2013) Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy. Nat Struct Mol Biol 20: 671-678
50. Stong N, Deng Z, Gupta R, Hu S, Paul S, Weiner AK, Eichler EE, Graves T, Fronick CC, Courtney L, Wilson RK, Lieberman PM, Davuluri RV, Riethman H, (2014) Subtelomeric CTCF and cohesin binding site organization using improved subtelomere assemblies and a novel annotation pipeline. Genome Res 24: 1039-1050
51. Suram A, Herbig U, (2014) The replicometer is broken: telomeres activate cellular senescence in response to genotoxic stresses. Aging Cell 13: 780-786
52. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS, McMahon SB, (2006) Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24: 841-851
53. Taberlay PC, Statham AL, Kelly TK, Clark SJ, Jones PA, (2014) Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer. Genome Res 24: 1421-1432
54. Tempel S, (2012) Using and understanding RepeatMasker. Methods Mol Biol 859: 29-51
55. Wang T, Zeng J, Lowe CB, Sellers RG, Salama SR, Yang M, Burgess SM, Brachmann RK, Haussler D, (2007) Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53. Proc Natl Acad Sci USA 104: 18613-18618
56. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, Chew JL, Lee YL, Kuznetsov VA, Sung WK, Miller LD, Lim B, Liu ET, Yu Q, et al, (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124: 207-219
57. Xin H, Liu D, Songyang Z, (2008) The telosome/shelterin complex and its functions. Genome Biol 9: 232
58. Youngman S, Bates GP, Williams S, McClatchey AI, Baxendale S, Sedlacek Z, Altherr M, Wasmuth JJ, MacDonald ME, Gusella JF, Sheer D, Lehrach H, (1992) The telomeric 60 kb of chromosome arm 4p is homologous to telomeric regions on 13p, 15p, 21p, and 22p. Genomics 14: 350-356